I am an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington, primarily working clinically at Harborview Medical Center. I work with the Recovery Clinic, Intake and Brief Intervention Services (IBIS), the Behavioral Health Integration Program (BHIP), and Addiction Consult Service.
I am fellowship-trained in Addiction Psychiatry, and board certified in both general and addiction psychiatry by the American Board of Psychiatry and Neurology. My passion is providing excellent, compassionate and comprehensive psychiatric care to my patients regardless of background or resources. I believe quality healthcare is a human right for all people and am excited help make that a reality as part of the Harborview system.
My lab develops and tests acceptance-based therapies delivered in digital and telehealth platforms, with a focus on addressing health disparities. The most preventable causes of premature death and human suffering are cigarette smoking and obesity. To this end, my research team focuses on designing, developing, and testing AI-based chatbot, smartphone app-delivered, and telephone coach-delivered contextual behavioral interventions for smoking cessation and for weight loss. Research aims include main outcome comparisons, mediators, moderators, intervention engagement, and therapeutic process predictors of outcome. This research is currently supported by multiple NIH R01-level grants. Our lab’s latest grant focuses on testing a smartphone app for helping American Indians and Alaska Natives stop smoking commercial cigarettes.
See links for further information:
https://research.fredhutch.org/habit/en/habit-group-members.html
https://en.wikipedia.org/wiki/Jonathan_Bricker
I am a clinical psychologist by training and an Assistant Professor at the University of Washington, Department of Psychiatry and Behavioral Sciences. I am also a Health Service Research Scientist at the Seattle-Denver HSR&D Center of Innovation for Veteran-Centered and Value-Driven Care at the VA Puget Sound Health Care System. My research program broadly focuses on bringing a more holistic approach to healthcare (i.e., mind, body, and spirit) and centers around two interconnected areas of investigation: 1) meaning-making and meaning in life among individuals with chronic pain and psychological distress (in particular, PTSD) and 2) developing and testing mind-body interventions that improve physical and emotional health and well-being. I am particularly interested in improving health for those in rural settings. My work has been supported by the National Center for Complementary and Integrative Health and the U.S. Department of Veterans Affairs.
Lupita Santillan, PhD, is an Acting Assistant Professor in the department of Psychiatry and Behavioral Sciences. Dr. Santillan is an attending psychologist for the Early Childhood Clinic and the CALMA Clinic at Seattle Children’s Hospital. She is passionate about increasing access to evidence-based early childhood interventions and the provision of mental and behavioral health in Spanish. Her clinical training has focused on providing care to families and children with developmental delays and neurodevelopmental disabilities. Dr. Santillan’s research focuses on the development, implementation, and efficacy of evidence-based behavioral treatments to support children with developmental delays and neurodevelopmental disabilities.
Dr. Dahyeon Kang is an Assistant Professor at the University of Washington School of Medicine. She earned her doctoral degree from the University of Illinois at Urbana-Champaign, where her work focused on the etiology of alcohol and substance use disorders through multimodal research methods, including alcohol administration, neuroimaging, transdermal biosensors, and ecological momentary assessments. At the University of Washington’s Department of Psychiatry, Dr. Kang investigates how individual and social factors interact to influence alcohol and cannabis use behaviors.
Dr. Sandel-Fernandez’s research is focused on predicting impulsive and risk behaviors as they occur in people’s daily lives. She has conducted numerous studies using ecological momentary assessment (EMA) and self-monitoring data from therapy to build person-specific models of symptom dynamics including self-harm, substance use, and suicide attempts.
Dr. Sandel-Fernandez often takes an idiographic (person-specific) analysis approach to answer the question of when in time a person is most at risk for engaging in behaviors they would like to avoid, based on their context, emotions, and personal triggers. Her career goal is to improve treatment outcomes by tailoring evidence-based care to people’s diverse symptom experiences.
My research focuses on improving clinical outcome measures and intervention outcomes for individuals with Down syndrome, neurodevelopmental disorders, and other special healthcare needs. I conduct research in real-world, clinical settings using multiple different tools, including caregiver-report, behavioral assessments, and electroencephalography (EEG) to study the development of and interventions for challenging behaviors. I am currently a KL2 INCLUDE Scholar conducting research on cognitive abilities and challenging behaviors in youth with Down syndrome.
As a clinical and quantitative psychologist, my work bridges statistical practice and psychological theory to better identify for whom, under what conditions, and why substance-related health disparities are greatest across development. My substantive research seeks to understand how individual differences in stress and developing self-regulation shape substance use and disorder from adolescence through young adulthood, and how these associations explain substance use disparities among sexual and gender minoritized communities. Stemming from this work, my methodological research is centered on improving the analysis and interpretation of nonlinear effects spanning parametric and non-parametric methodologies.
Dr. Samantha J. Reznik (she/her) is an Assistant Professor and licensed clinical psychologist in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine. She is the Director for Seattle Children’s Psychosis Program, providing holistic mental health care to support individuals with psychosis ages 13-21 to reach goals aligned with personal values and passions. With a commitment to research, training, and clinical leadership in serious mental illness (SMI), she strives to create meaningful change in mental health services, ensuring individuals receive the recovery-oriented care they deserve.
As an investigator at the Supporting Psychosis Innovation through Research, Implementation, & Training (SPIRIT) Center, she focuses on dissemination and implementation research to increase access to and quality of care for individuals with SMI and other underserved populations. She currently supports the Central Assessment for Psychosis (CAPS) project to increase access to psychosis assessment and reduce barriers to early psychosis treatment engagement across Washington. She is also committed to advancing SMI and health service psychology training and is actively involved in related national service, including serving as the Chair-Elect of the APA SMI/SED Subsection and founding member and Co-Chair of SMI Future of Academia, Training, and Education (FATE) committee to advance doctoral psychology training in SMI.
Dr. Reznik earned her PhD in Clinical Psychology at the University of Arizona with a focus on psychophysiology and intervention science. Her clinical training included a Health Resources and Services Administration (HRSA)-funded Underserved Track clinical internship at University of Kansas Medical Center as well as an advanced clinical fellowship in rehabilitation and recovery for SMI at VA San Diego Healthcare System/University of California San Diego. She was previously a Research Assistant Professor at the University of Texas at Austin and investigator with the Advancing Early Psychosis Intervention Network in Texas (EPINET-TX) project.
